Drugs Made In America Acquisition Corp. (DMAAR)
NASDAQ
Drugs Made In America Acquisition Corp. Stock Price History
Drugs Made In America Acquisition Corp.
Loading…
Historical daily closing price for Drugs Made In America Acquisition Corp. since 2025, adjusted for splits and dividends. The latest closing stock price for Drugs Made In America Acquisition Corp. as of June 10, 2026 is 0.10.
- The all-time high Drugs Made In America Acquisition Corp. stock closing price was 0.23 on September 26, 2025.
- The Drugs Made In America Acquisition Corp. 52-week high stock price is 0.23, which is 130.0% above the current share price.
- The Drugs Made In America Acquisition Corp. 52-week low stock price is 0.04, which is 56.5% below the current share price.
- The average Drugs Made In America Acquisition Corp. stock price for the last 52 weeks is 0.14.
Annual Close Price
YEAR-END CLOSE · USD
ANNUAL % CHANGE · %
| Year | Average | Year Open | Year High | Year Low | Year Close | Annual % Change |
|---|---|---|---|---|---|---|
| 2026 | 0.10 | 0.16 | 0.16 | 0.04 | 0.10 | -36.67% |
| 2025 | 0.17 | 0.15 | 0.23 | 0.10 | 0.16 | — |
Drugs Made In America Acquisition Corp. Stock Price History — FAQ
Drugs Made In America Acquisition Corp. (DMAAR) stock price history — annual and quarterly figures with year-over-year growth and charts.
Where can I see DMAAR's stock price history history?
The chart and table above show Drugs Made In America Acquisition Corp.'s stock price history by year and by quarter, including the growth rate.